Selected research
Industry Research
Insulin Needle-free Injection Pen Industry Research Report 2026
Market perspective
The global Insulin Needle-free Injection Pen market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Insulin Needle-free Injection Pen is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Insulin Needle-free Injection Pen is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Insulin Needle-free Injection Pen include Portal Instruments, Injex Pharma, JSK Biomed, Glide Pharma, Antares Pharma, Inc., InsuJet, Miracle Medical, Crossject SA and PharmaJet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Insulin Needle-free Injection Pen market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Insulin Needle-free Injection Pen Market by Company
Portal Instruments
Injex Pharma
JSK Biomed
Glide Pharma
Antares Pharma, Inc.
InsuJet
Miracle Medical
Crossject SA
PharmaJet
Mika Medical
Lepu Medical Technology (Beijing) Co., Ltd.
Shandong Zhongbaokang Medical Equipment Co.,Ltd
Jiangxi Sanxin Medtec Co.,Ltd.
Quinovare
Joyomed Suzhou Co.,Ltd.
Sinocare
Insulin Needle-free Injection Pen Segment by Type
Mechanical Force
Electric Force
Optical Force
Insulin Needle-free Injection Pen Segment by Application
Hospital & Clinic
Retail Pharmacies
Online Channel
Insulin Needle-free Injection Pen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Needle-free Injection Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin Needle-free Injection Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Needle-free Injection Pen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Insulin Needle-free Injection Pen manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Insulin Needle-free Injection Pen by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Insulin Needle-free Injection Pen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Insulin Needle-free Injection Pen Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Insulin Needle-free Injection Pen Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Insulin Needle-free Injection Pen Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Insulin Needle-free Injection Pen Revenue of Manufacturers (2021-2026)
Table 9. Global Insulin Needle-free Injection Pen Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Insulin Needle-free Injection Pen Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Insulin Needle-free Injection Pen Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Insulin Needle-free Injection Pen, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Insulin Needle-free Injection Pen, Product Type & Application
Table 14. Global Insulin Needle-free Injection Pen Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Insulin Needle-free Injection Pen by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Portal Instruments Company Information
Table 19. Portal Instruments Business Overview
Table 20. Portal Instruments Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Portal Instruments Insulin Needle-free Injection Pen Product Portfolio
Table 22. Portal Instruments Recent Developments
Table 23. Injex Pharma Company Information
Table 24. Injex Pharma Business Overview
Table 25. Injex Pharma Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Injex Pharma Insulin Needle-free Injection Pen Product Portfolio
Table 27. Injex Pharma Recent Developments
Table 28. JSK Biomed Company Information
Table 29. JSK Biomed Business Overview
Table 30. JSK Biomed Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. JSK Biomed Insulin Needle-free Injection Pen Product Portfolio
Table 32. JSK Biomed Recent Developments
Table 33. Glide Pharma Company Information
Table 34. Glide Pharma Business Overview
Table 35. Glide Pharma Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Glide Pharma Insulin Needle-free Injection Pen Product Portfolio
Table 37. Glide Pharma Recent Developments
Table 38. Antares Pharma, Inc. Company Information
Table 39. Antares Pharma, Inc. Business Overview
Table 40. Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Portfolio
Table 42. Antares Pharma, Inc. Recent Developments
Table 43. InsuJet Company Information
Table 44. InsuJet Business Overview
Table 45. InsuJet Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. InsuJet Insulin Needle-free Injection Pen Product Portfolio
Table 47. InsuJet Recent Developments
Table 48. Miracle Medical Company Information
Table 49. Miracle Medical Business Overview
Table 50. Miracle Medical Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Miracle Medical Insulin Needle-free Injection Pen Product Portfolio
Table 52. Miracle Medical Recent Developments
Table 53. Crossject SA Company Information
Table 54. Crossject SA Business Overview
Table 55. Crossject SA Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Crossject SA Insulin Needle-free Injection Pen Product Portfolio
Table 57. Crossject SA Recent Developments
Table 58. PharmaJet Company Information
Table 59. PharmaJet Business Overview
Table 60. PharmaJet Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. PharmaJet Insulin Needle-free Injection Pen Product Portfolio
Table 62. PharmaJet Recent Developments
Table 63. Mika Medical Company Information
Table 64. Mika Medical Business Overview
Table 65. Mika Medical Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Mika Medical Insulin Needle-free Injection Pen Product Portfolio
Table 67. Mika Medical Recent Developments
Table 68. Lepu Medical Technology (Beijing) Co., Ltd. Company Information
Table 69. Lepu Medical Technology (Beijing) Co., Ltd. Business Overview
Table 70. Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Portfolio
Table 72. Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
Table 73. Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information
Table 74. Shandong Zhongbaokang Medical Equipment Co.,Ltd Business Overview
Table 75. Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Portfolio
Table 77. Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Developments
Table 78. Jiangxi Sanxin Medtec Co.,Ltd. Company Information
Table 79. Jiangxi Sanxin Medtec Co.,Ltd. Business Overview
Table 80. Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
Table 82. Jiangxi Sanxin Medtec Co.,Ltd. Recent Developments
Table 83. Quinovare Company Information
Table 84. Quinovare Business Overview
Table 85. Quinovare Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Quinovare Insulin Needle-free Injection Pen Product Portfolio
Table 87. Quinovare Recent Developments
Table 88. Joyomed Suzhou Co.,Ltd. Company Information
Table 89. Joyomed Suzhou Co.,Ltd. Business Overview
Table 90. Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
Table 92. Joyomed Suzhou Co.,Ltd. Recent Developments
Table 93. Sinocare Company Information
Table 94. Sinocare Business Overview
Table 95. Sinocare Insulin Needle-free Injection Pen Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Sinocare Insulin Needle-free Injection Pen Product Portfolio
Table 97. Sinocare Recent Developments
Table 98. Global Insulin Needle-free Injection Pen Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 99. Global Insulin Needle-free Injection Pen Sales by Region (2021-2026) & (k units)
Table 100. Global Insulin Needle-free Injection Pen Sales Market Share by Region (2021-2026)
Table 101. Global Insulin Needle-free Injection Pen Sales by Region (2027-2032) & (k units)
Table 102. Global Insulin Needle-free Injection Pen Sales Market Share by Region (2027-2032)
Table 103. Global Insulin Needle-free Injection Pen Revenue by Region (2021-2026) & (US$ Million)
Table 104. Global Insulin Needle-free Injection Pen Revenue Market Share by Region (2021-2026)
Table 105. Global Insulin Needle-free Injection Pen Revenue by Region (2027-2032) & (US$ Million)
Table 106. Global Insulin Needle-free Injection Pen Revenue Market Share by Region (2027-2032)
Table 107. North America Insulin Needle-free Injection Pen Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. North America Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units)
Table 109. North America Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units)
Table 110. North America Insulin Needle-free Injection Pen Revenue by Country (2021-2026) & (US$ Million)
Table 111. North America Insulin Needle-free Injection Pen Revenue by Country (2027-2032) & (US$ Million)
Table 112. Europe Insulin Needle-free Injection Pen Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Europe Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units)
Table 114. Europe Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units)
Table 115. Europe Insulin Needle-free Injection Pen Revenue by Country (2021-2026) & (US$ Million)
Table 116. Europe Insulin Needle-free Injection Pen Revenue by Country (2027-2032) & (US$ Million)
Table 117. Asia Pacific Insulin Needle-free Injection Pen Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Asia Pacific Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units)
Table 119. Asia Pacific Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units)
Table 120. Asia Pacific Insulin Needle-free Injection Pen Revenue by Country (2021-2026) & (US$ Million)
Table 121. Asia Pacific Insulin Needle-free Injection Pen Revenue by Country (2027-2032) & (US$ Million)
Table 122. South America Insulin Needle-free Injection Pen Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. South America Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units)
Table 124. South America Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units)
Table 125. South America Insulin Needle-free Injection Pen Revenue by Country (2021-2026) & (US$ Million)
Table 126. South America Insulin Needle-free Injection Pen Revenue by Country (2027-2032) & (US$ Million)
Table 127. Middle East and Africa Insulin Needle-free Injection Pen Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2021-2026) & (k units)
Table 129. Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2027-2032) & (k units)
Table 130. Middle East and Africa Insulin Needle-free Injection Pen Revenue by Country (2021-2026) & (US$ Million)
Table 131. Middle East and Africa Insulin Needle-free Injection Pen Revenue by Country (2027-2032) & (US$ Million)
Table 132. Global Insulin Needle-free Injection Pen Sales by Type (2021-2026) & (k units)
Table 133. Global Insulin Needle-free Injection Pen Sales by Type (2027-2032) & (k units)
Table 134. Global Insulin Needle-free Injection Pen Sales Market Share by Type (2021-2026)
Table 135. Global Insulin Needle-free Injection Pen Sales Market Share by Type (2027-2032)
Table 136. Global Insulin Needle-free Injection Pen Revenue by Type (2021-2026) & (US$ Million)
Table 137. Global Insulin Needle-free Injection Pen Revenue by Type (2027-2032) & (US$ Million)
Table 138. Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2021-2026)
Table 139. Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2027-2032)
Table 140. Global Insulin Needle-free Injection Pen Price by Type (2021-2026) & (USD/unit)
Table 141. Global Insulin Needle-free Injection Pen Price by Type (2027-2032) & (USD/unit)
Table 142. Global Insulin Needle-free Injection Pen Sales by Application (2021-2026) & (k units)
Table 143. Global Insulin Needle-free Injection Pen Sales by Application (2027-2032) & (k units)
Table 144. Global Insulin Needle-free Injection Pen Sales Market Share by Application (2021-2026)
Table 145. Global Insulin Needle-free Injection Pen Sales Market Share by Application (2027-2032)
Table 146. Global Insulin Needle-free Injection Pen Revenue by Application (2021-2026) & (US$ Million)
Table 147. Global Insulin Needle-free Injection Pen Revenue by Application (2027-2032) & (US$ Million)
Table 148. Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2021-2026)
Table 149. Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2027-2032)
Table 150. Global Insulin Needle-free Injection Pen Price by Application (2021-2026) & (USD/unit)
Table 151. Global Insulin Needle-free Injection Pen Price by Application (2027-2032) & (USD/unit)
Table 152. Key Raw Materials
Table 153. Raw Materials Key Suppliers
Table 154. Insulin Needle-free Injection Pen Distributors List
Table 155. Insulin Needle-free Injection Pen Customers List
Table 156. Insulin Needle-free Injection Pen Industry Trends
Table 157. Insulin Needle-free Injection Pen Industry Drivers
Table 158. Insulin Needle-free Injection Pen Industry Restraints
Table 159. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Insulin Needle-free Injection Pen Product Image
Figure 5. Global Insulin Needle-free Injection Pen Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Insulin Needle-free Injection Pen Market Size (2021-2032) & (US$ Million)
Figure 7. Global Insulin Needle-free Injection Pen Sales (2021-2032) & (k units)
Figure 8. Global Insulin Needle-free Injection Pen Average Price (USD/unit) & (2021-2032)
Figure 9. Mechanical Force Product Image
Figure 10. Electric Force Product Image
Figure 11. Optical Force Product Image
Figure 12. Hospital & Clinic Product Image
Figure 13. Retail Pharmacies Product Image
Figure 14. Online Channel Product Image
Figure 15. Global Insulin Needle-free Injection Pen Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Insulin Needle-free Injection Pen, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Insulin Needle-free Injection Pen Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Insulin Needle-free Injection Pen Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Insulin Needle-free Injection Pen Sales by Region in 2025
Figure 21. Global Insulin Needle-free Injection Pen Revenue by Region in 2025
Figure 22. North America Insulin Needle-free Injection Pen Market Size by Country in 2025
Figure 23. North America Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032)
Figure 24. North America Insulin Needle-free Injection Pen Revenue Market Share by Country (2021-2032)
Figure 25. United States Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Insulin Needle-free Injection Pen Market Size by Country in 2025
Figure 29. Europe Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032)
Figure 30. Europe Insulin Needle-free Injection Pen Revenue Market Share by Country (2021-2032)
Figure 31. Germany Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Insulin Needle-free Injection Pen Market Size by Country in 2025
Figure 42. Asia Pacific Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Insulin Needle-free Injection Pen Revenue Market Share by Country (2021-2032)
Figure 44. China Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Insulin Needle-free Injection Pen Market Size by Country in 2025
Figure 53. South America Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032)
Figure 54. South America Insulin Needle-free Injection Pen Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Middle East and Africa Insulin Needle-free Injection Pen Market Size by Country in 2025
Figure 59. Middle East and Africa Insulin Needle-free Injection Pen Sales Market Share by Country (2021-2032)
Figure 60. Middle East and Africa Insulin Needle-free Injection Pen Revenue Market Share by Country (2021-2032)
Figure 61. Egypt Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. South Africa Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Israel Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Türkiye Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. GCC Countries Insulin Needle-free Injection Pen Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Global Insulin Needle-free Injection Pen Sales Market Share by Type (2021-2032)
Figure 67. Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2021-2032)
Figure 68. Global Insulin Needle-free Injection Pen Price (USD/unit) by Type (2021-2032)
Figure 69. Global Insulin Needle-free Injection Pen Sales Market Share by Application (2021-2032)
Figure 70. Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2021-2032)
Figure 71. Global Insulin Needle-free Injection Pen Price (USD/unit) by Application (2021-2032)
Figure 72. Insulin Needle-free Injection Pen Value Chain
Figure 73. Insulin Needle-free Injection Pen Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Insulin Needle-free Injection Pen Industry Opportunities and Challenges
Scope & coverage.
Types
- Mechanical Force
- Electric Force
- Optical Force
Applications
- Hospital & Clinic
- Retail Pharmacies
- Online Channel
Companies covered
- Portal Instruments
- Injex Pharma
- JSK Biomed
- Glide Pharma
- Antares Pharma, Inc.
- InsuJet
- Miracle Medical
- Crossject SA
- PharmaJet
- Mika Medical
- Lepu Medical Technology (Beijing) Co., Ltd.
- Shandong Zhongbaokang Medical Equipment Co.,Ltd
- Jiangxi Sanxin Medtec Co.,Ltd.
- Quinovare
- Joyomed Suzhou Co.,Ltd.
- Sinocare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Insulin Needle-free Injection Pen Market Size (2021-2032)
- 2.2.2 Global Insulin Needle-free Injection Pen Sales (2021-2032)
- 2.2.3 Global Insulin Needle-free Injection Pen Market Average Price (2021-2032)
- 2.3 Insulin Needle-free Injection Pen by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mechanical Force
- 2.3.3 Electric Force
- 2.3.4 Optical Force
- 2.4 Insulin Needle-free Injection Pen by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital & Clinic
- 2.4.3 Retail Pharmacies
- 2.4.4 Online Channel
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Insulin Needle-free Injection Pen Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Insulin Needle-free Injection Pen Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Insulin Needle-free Injection Pen Revenue of Manufacturers (2021-2026)
- 3.4 Global Insulin Needle-free Injection Pen Average Price by Manufacturers (2021-2026)
- 3.5 Global Insulin Needle-free Injection Pen Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Insulin Needle-free Injection Pen, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Insulin Needle-free Injection Pen, Product Type & Application
- 3.8 Global Manufacturers of Insulin Needle-free Injection Pen, Established Date
- 3.9 Global Insulin Needle-free Injection Pen Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Portal Instruments
- 4.1.1 Portal Instruments Company Information
- 4.1.2 Portal Instruments Business Overview
- 4.1.3 Portal Instruments Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Portal Instruments Insulin Needle-free Injection Pen Product Portfolio
- 4.1.5 Portal Instruments Recent Developments
- 4.2 Injex Pharma
- 4.2.1 Injex Pharma Company Information
- 4.2.2 Injex Pharma Business Overview
- 4.2.3 Injex Pharma Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Injex Pharma Insulin Needle-free Injection Pen Product Portfolio
- 4.2.5 Injex Pharma Recent Developments
- 4.3 JSK Biomed
- 4.3.1 JSK Biomed Company Information
- 4.3.2 JSK Biomed Business Overview
- 4.3.3 JSK Biomed Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 JSK Biomed Insulin Needle-free Injection Pen Product Portfolio
- 4.3.5 JSK Biomed Recent Developments
- 4.4 Glide Pharma
- 4.4.1 Glide Pharma Company Information
- 4.4.2 Glide Pharma Business Overview
- 4.4.3 Glide Pharma Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glide Pharma Insulin Needle-free Injection Pen Product Portfolio
- 4.4.5 Glide Pharma Recent Developments
- 4.5 Antares Pharma, Inc.
- 4.5.1 Antares Pharma, Inc. Company Information
- 4.5.2 Antares Pharma, Inc. Business Overview
- 4.5.3 Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Portfolio
- 4.5.5 Antares Pharma, Inc. Recent Developments
- 4.6 InsuJet
- 4.6.1 InsuJet Company Information
- 4.6.2 InsuJet Business Overview
- 4.6.3 InsuJet Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 InsuJet Insulin Needle-free Injection Pen Product Portfolio
- 4.6.5 InsuJet Recent Developments
- 4.7 Miracle Medical
- 4.7.1 Miracle Medical Company Information
- 4.7.2 Miracle Medical Business Overview
- 4.7.3 Miracle Medical Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Miracle Medical Insulin Needle-free Injection Pen Product Portfolio
- 4.7.5 Miracle Medical Recent Developments
- 4.8 Crossject SA
- 4.8.1 Crossject SA Company Information
- 4.8.2 Crossject SA Business Overview
- 4.8.3 Crossject SA Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Crossject SA Insulin Needle-free Injection Pen Product Portfolio
- 4.8.5 Crossject SA Recent Developments
- 4.9 PharmaJet
- 4.9.1 PharmaJet Company Information
- 4.9.2 PharmaJet Business Overview
- 4.9.3 PharmaJet Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 PharmaJet Insulin Needle-free Injection Pen Product Portfolio
- 4.9.5 PharmaJet Recent Developments
- 4.10 Mika Medical
- 4.10.1 Mika Medical Company Information
- 4.10.2 Mika Medical Business Overview
- 4.10.3 Mika Medical Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mika Medical Insulin Needle-free Injection Pen Product Portfolio
- 4.10.5 Mika Medical Recent Developments
- 4.11 Lepu Medical Technology (Beijing) Co., Ltd.
- 4.11.1 Lepu Medical Technology (Beijing) Co., Ltd. Company Information
- 4.11.2 Lepu Medical Technology (Beijing) Co., Ltd. Business Overview
- 4.11.3 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Portfolio
- 4.11.5 Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
- 4.12 Shandong Zhongbaokang Medical Equipment Co.,Ltd
- 4.12.1 Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information
- 4.12.2 Shandong Zhongbaokang Medical Equipment Co.,Ltd Business Overview
- 4.12.3 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Portfolio
- 4.12.5 Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Developments
- 4.13 Jiangxi Sanxin Medtec Co.,Ltd.
- 4.13.1 Jiangxi Sanxin Medtec Co.,Ltd. Company Information
- 4.13.2 Jiangxi Sanxin Medtec Co.,Ltd. Business Overview
- 4.13.3 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
- 4.13.5 Jiangxi Sanxin Medtec Co.,Ltd. Recent Developments
- 4.14 Quinovare
- 4.14.1 Quinovare Company Information
- 4.14.2 Quinovare Business Overview
- 4.14.3 Quinovare Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Quinovare Insulin Needle-free Injection Pen Product Portfolio
- 4.14.5 Quinovare Recent Developments
- 4.15 Joyomed Suzhou Co.,Ltd.
- 4.15.1 Joyomed Suzhou Co.,Ltd. Company Information
- 4.15.2 Joyomed Suzhou Co.,Ltd. Business Overview
- 4.15.3 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
- 4.15.5 Joyomed Suzhou Co.,Ltd. Recent Developments
- 4.16 Sinocare
- 4.16.1 Sinocare Company Information
- 4.16.2 Sinocare Business Overview
- 4.16.3 Sinocare Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Sinocare Insulin Needle-free Injection Pen Product Portfolio
- 4.16.5 Sinocare Recent Developments
5 Global Insulin Needle-free Injection Pen Market Scenario by Region
- 5.1 Global Insulin Needle-free Injection Pen Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Insulin Needle-free Injection Pen Sales by Region: 2021-2032
- 5.2.1 Global Insulin Needle-free Injection Pen Sales by Region: 2021-2026
- 5.2.2 Global Insulin Needle-free Injection Pen Sales by Region: 2027-2032
- 5.3 Global Insulin Needle-free Injection Pen Revenue by Region: 2021-2032
- 5.3.1 Global Insulin Needle-free Injection Pen Revenue by Region: 2021-2026
- 5.3.2 Global Insulin Needle-free Injection Pen Revenue by Region: 2027-2032
- 5.4 North America Insulin Needle-free Injection Pen Market Facts & Figures by Country
- 5.4.1 North America Insulin Needle-free Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Insulin Needle-free Injection Pen Sales by Country (2021-2032)
- 5.4.3 North America Insulin Needle-free Injection Pen Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Insulin Needle-free Injection Pen Market Facts & Figures by Country
- 5.5.1 Europe Insulin Needle-free Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Insulin Needle-free Injection Pen Sales by Country (2021-2032)
- 5.5.3 Europe Insulin Needle-free Injection Pen Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Insulin Needle-free Injection Pen Market Facts & Figures by Country
- 5.6.1 Asia Pacific Insulin Needle-free Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Insulin Needle-free Injection Pen Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Insulin Needle-free Injection Pen Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Insulin Needle-free Injection Pen Market Facts & Figures by Country
- 5.7.1 South America Insulin Needle-free Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Insulin Needle-free Injection Pen Sales by Country (2021-2032)
- 5.7.3 South America Insulin Needle-free Injection Pen Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Insulin Needle-free Injection Pen Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Insulin Needle-free Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Insulin Needle-free Injection Pen Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Insulin Needle-free Injection Pen Sales by Type (2021-2032)
- 6.1.1 Global Insulin Needle-free Injection Pen Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Insulin Needle-free Injection Pen Sales Market Share by Type (2021-2032)
- 6.2 Global Insulin Needle-free Injection Pen Revenue by Type (2021-2032)
- 6.2.1 Global Insulin Needle-free Injection Pen Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Insulin Needle-free Injection Pen Revenue Market Share by Type (2021-2032)
- 6.3 Global Insulin Needle-free Injection Pen Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Insulin Needle-free Injection Pen Sales by Application (2021-2032)
- 7.1.1 Global Insulin Needle-free Injection Pen Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Insulin Needle-free Injection Pen Sales Market Share by Application (2021-2032)
- 7.2 Global Insulin Needle-free Injection Pen Revenue by Application (2021-2032)
- 7.2.1 Global Insulin Needle-free Injection Pen Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Insulin Needle-free Injection Pen Revenue Market Share by Application (2021-2032)
- 7.3 Global Insulin Needle-free Injection Pen Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Insulin Needle-free Injection Pen Value Chain Analysis
- 8.1.1 Insulin Needle-free Injection Pen Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Insulin Needle-free Injection Pen Production Mode & Process
- 8.2 Insulin Needle-free Injection Pen Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Insulin Needle-free Injection Pen Distributors
- 8.2.3 Insulin Needle-free Injection Pen Customers
9 Global Insulin Needle-free Injection Pen Analyzing Market Dynamics
- 9.1 Insulin Needle-free Injection Pen Industry Trends
- 9.2 Insulin Needle-free Injection Pen Industry Drivers
- 9.3 Insulin Needle-free Injection Pen Industry Opportunities and Challenges
- 9.4 Insulin Needle-free Injection Pen Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst